Company attributes
Industry
B2X
Founder
Pitchbook URL
Legal Name
Gracell Biotechnologies Inc.
Legal classification
Number of Employees (Ranges)
201 – 500
Email Address
career@gracellbio.com
info@gracellbio.com
Full Address
Building 12, Block B, Phase II Biobay Industrial Park 218 Sangtian St. Suzhou Industrial Park Shanghai, Jiangsu 215123 China
CIK Number
Place of Incorporation
Investors
Founded Date
2017
Total Funding Amount (USD)
370,000,000
Latest Funding Round Date
October 29, 2020
Stock Symbol
GRCL
Exchange
Board of Directors
Also Known As
Gracell Biotechnologies
Latest Funding Type
Technologies Used
Country
Headquarters
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
100,000,000
SIC Code
2,834
Gracell Biotechnology is a developer of cancer treatments, developing cellular therapeutics for patients suffering from hematological malignancy, solid tumors, or degenerative diseases.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
